Characterizing inherited muscle disease with Paget bone disease
Official title: Characterization of Familial Myopathy and Paget Disease of Bone
Run by University of California, Irvine · NCT01166854 · Data updated 2026-11-12
This observational study will use painless infrared tissue scans and genetic analysis to try to find inherited causes of combined muscle and bone disorders in adults and their family members.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 25 (estimated) |
| Sponsor | University of California, Irvine Academic / other |
| Drugs / interventions | radiation |
| Locations | 1 site (Irvine, California) |
| Status | Recruiting |
| Started | June 18, 2010 |
| Main results expected | June 2030 |
| Study ends | June 2030 |
| Registry record updated | June 18, 2025 |
| Trial ID | NCT01166854 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (18 and older) who have both muscle and bone disorders that appear hereditary, and their family members, are ideal candidates for this study.
✕Probably not a fit
People without a personal or family history of combined muscle and bone disorders, or individuals under age 18, are unlikely to receive direct benefit from participation.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is an observational, family-based investigation of adults who have both muscle and bone disorders that appear to run in families. Researchers will collect clinical and family history information, perform genetic studies, and use Diffuse Optical Spectroscopy to measure tissue blood, water, and lipid content at sites such as the calf, bicep, or head. The spectroscopy measurement is noninvasive and painless, involves placing a small probe on the skin, and is repeated on marked locations to ensure consistency. Study results aim to improve understanding of how inherited genetic changes affect muscle and bone physiology and metabolism.
Why it matters
Potential benefit: If successful, the project could identify genetic causes that improve diagnosis and guide future therapies for families with combined muscle and Paget bone disease.
How similar studies have gone: Prior genetic research has identified some genes linked to Paget disease and certain myopathies, though combining detailed tissue optical measurements with family genetics is a relatively novel approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: Male or Female age 18 and older * diagnose of Muscle or bone disorders * with a combination of medical problems including muscle and bone disease and their family members. Exclusion Criteria: * under 18 year of age * unrelated diagnosis
Where it's running
-
Hewitt Hall
Irvine, California, United States Recruiting
Study contacts
- Principal investigator: Virginia Kimonis, MD — Beckman Laser Institute University of California Irvine
- Study coordinator: Marie Wencel, BS
- Email: mwencel@uci.edu
- Phone: 949-824-0521
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Collection of biological samples from patients with bone and growth plate disorders
This study is collecting samples from children with bone and growth plate disorders to better understand their conditions and find new ways to help them.
-
Pilot test of an active surveillance approach for brain metastases during CNS-penetrant systemic therapy
A small observational study tests whether an active surveillance plan for newly progressing brain metastases during CNS-penetrant systemic therapy is safe for patients.
-
Nerve block to treat severe belly pain in the emergency department
This study tests whether injecting anesthesia into the erector spinae plane can relieve non-surgical abdominal pain in the ED without relying on narcotics.
-
Paclitaxel given inside the abdomen with systemic therapy for GI cancers with peritoneal spread
This phase II study tests a combination of intraperitoneal and systemic chemotherapy (paclitaxel) in adults with digestive tract cancers that have spread to the peritoneum.
-
Empowering patients to get lung cancer screening with support and navigation
This pilot study tests a patient navigation and education program to see if it helps adults who are eligible start and complete low-dose CT lung cancer screening.
-
Metformin in PMP from appendiceal mucinous neoplasms
This pilot study tests whether metformin is feasible to use in adults with pseudomyxoma peritonei caused by appendiceal mucinous tumors who have recurrent or unresected disease.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.